Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Filters and open-heart surgery

Thomas Wechsler1

  • 1Sefar Inc., Filtration Division, Rüschlikon, Switzerland. thomas.wechsler@fd.sefar.ch

Medical Device Technology
|July 16, 2002
PubMed
Summary

No abstract available in PubMed .

Related Experiment Videos

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

AAV9-NGLY1 gene replacement therapy improves phenotypic and biomarker endpoints in a rat model of NGLY1 Deficiency.

Molecular therapy. Methods & clinical development·2022
Same author

GlcNAc-Asn is a biomarker for NGLY1 deficiency.

Journal of biochemistry·2021
Same author

ZFN-mediated in vivo gene editing in hepatocytes leads to supraphysiologic α-Gal A activity and effective substrate reduction in Fabry mice.

Molecular therapy : the journal of the American Society of Gene Therapy·2021
Same author

AAV2/6 Gene Therapy in a Murine Model of Fabry Disease Results in Supraphysiological Enzyme Activity and Effective Substrate Reduction.

Molecular therapy. Methods & clinical development·2020
Same author

ZFN-Mediated In Vivo Genome Editing Corrects Murine Hurler Syndrome.

Molecular therapy : the journal of the American Society of Gene Therapy·2018
Same author

Dose-Dependent Prevention of Metabolic and Neurologic Disease in Murine MPS II by ZFN-Mediated In Vivo Genome Editing.

Molecular therapy : the journal of the American Society of Gene Therapy·2018